First Full Agenda Released: How the 2023 World Digital Therapeutics Congress Charts the Course for Industry Leadership

The wave of digitalization, carrying the energy of innovation, is stirring the seas of transformation in the healthcare industry.

Medicine is both the vocation of healthcare professionals and an endeavor of science. Clinicians dedicate their compassion and expertise to prolonging life, while scientists drive medical advancement through exploration and innovation. Every breakthrough in medicine stems from a steadfast commitment to the value of life and the pursuit of scientific truth. As medicine converges with digital technology, a new era of deep integration is unfolding.

Aided by digital tools such as big data and artificial intelligence, an emerging medical paradigm integrating multiple cutting-edge technologies—Digital Therapeutics (DTx)—has emerged. Digital Therapeutics achieves comprehensive and deep integration of digital tools with healthcare services, thereby significantly expanding physicians’ knowledge horizons and assisting them in making more accurate clinical judgments. By leveraging intelligent algorithms, it refines medical processes to deliver optimal treatment plans to every patient. Furthermore, it transforms doctor-patient interactions into a new stage characterized by information sharing and collaborative decision-making. In essence, it not only substantially improves the quality of care but also drives progress across the entire healthcare industry.

In recent years, digital therapeutics (DTx) have experienced rapid growth globally, with their immense value in empowering healthcare becoming increasingly evident. From the first DTx product receiving FDA approval in 2017, to the inclusion of “digital therapeutics” for the first time in a provincial-level national plan in the *Hainan Province’s 14th Five-Year Plan for Digital Health* in 2022, and further to the gradual implementation of the *Several Measures for Accelerating the Development of the Digital Therapeutics Industry in Hainan Province*, digital therapeutics have become a pivotal force driving transformation in the healthcare industry. As a prominent banner leading the global trend of the digital era in healthcare and a strategic pillar for the Healthy China initiative, digital therapeutics will promote high-quality development in health and wellness, significantly enhance the modernization of health governance, and provide digital solutions and innovative approaches to building a shared community of human health and well-being.

August 24-26, 2023, Haikou, Hainan, byHosted by Beijing Danhuang Technology Co., Ltd. (VB100, VCBeat, Eggshell Research Institute) and the China Primary Health Care Foundation; organized by Hainan Danhuang Technology Co., Ltd.; co-organized by the Youth Health Economics Committee of the Chinese Society of Health Economics; supported by the Digital Therapeutics Professional Committee of the China Association for Medical Device Industry, the UK Department for Business and Trade, and the Australian Trade and Investment Commission; with strategic partnership from AstraZeneca Investment (China) Co., Ltd. and Hainan Eco-Software Park“Pioneering a New Future for the Industrial Ecosystem, Jointly Building a Community of Common Health for Mankind” — The 2023 World Digital Therapeutics Conference will invite numerous distinguished guests and high-level industry representatives from domestic and international government agencies, academicians and scientists, clinical experts, and corporate leaders to jointly discuss, build, and share the development directions, cutting-edge trends, and cooperation opportunities in digital therapeutics.

Gathering of Industry Leaders: A Summit Dialogue to Co-Create a Healthier Future

This conference invites government officials, embassy and consulate representatives, academicians and experts in the digital health field from China and abroad, scholars from universities and research institutions in the healthcare sector, administrators of medical and health institutions, Fortune 500/listed companies, innovative enterprises, partners across the medical industry chain, and renowned financial investment institutions. By gathering cutting-edge insights, we aim to explore industry trends, facilitate industrial translation, foster deep collaborations, and jointly envision a new future for the digital therapeutics industry.

Anchoring Direction, Insight into Trends to Empower New Engines

Initiated and authored by VCBeat, with support from authoritative experts at the Hainan Provincial Health Commission, domestic and international digital therapeutics associations, enterprises, and other institutions, the “2023 Global Digital Therapeutics Industry Report” has been released. This report provides a multi-dimensional analysis covering indications, technological applications, clinical outcomes, delivery formats, payment innovations, and business models, showcasing the latest advancements in the digital therapeutics sector. It further explores industry opportunities, challenges, and response strategies, aiming to offer guiding references for governments, research institutes, entrepreneurs, and relevant stakeholders, thereby contributing to the development and long-term growth of the industry.

Standing at the Forefront: Uniting Strengths to Chart New Development

Taking this conference as a new starting point and Hainan as the epicenter, we will bring together academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, executives of multinational pharmaceutical and medical device companies and leading domestic healthcare enterprises, CEOs of listed companies, and renowned experts and scholars to jointly release the “Hainan Initiative on Digital Therapeutics.” This initiative aims to support Hainan in becoming a global innovation island for digital therapeutics, establish its status as a global innovation center for digital therapeutics, promote the empowerment of digital therapeutics within the global healthcare industry, and work together to build a new healthcare system and realize a Community of Common Health for Mankind.

Deepening Practice, Setting Benchmarks, and Demonstrating New Models

To recognize enterprises that have achieved outstanding results in innovation capability and potential, as well as in innovation practice and commercialization, the World Digital Therapeutics Conference is launching a call for nominations for the “Best Innovation and Practice Enterprises.” The conference will prominently release the 2023 World Digital Therapeutics Best Innovation and Practice Enterprise Cases. This initiative aims to focus on the ecosystem of digital therapeutics innovation and practice, identify the most innovative digital therapeutics companies, explore innovative applications and practices in digital health, build a platform for showcasing frontier research and application achievements in digital therapeutics, and empower brand growth for digital therapeutics enterprises.

Focusing on the Frontier, Weaving a New Landscape for Industrial Development

This conference features a Digital Health Interactive Experience Zone, divided into two major sections: the “International Digital Therapeutics Product Innovation Exhibition Area” and the “Hainan Digital Therapeutics Product Achievements Exhibition Area.” Spanning from global perspectives to Hainan’s local developments, it presents a multi-dimensional and comprehensive overview of the progress in digital therapeutics, including policy support, financing volumes, clinical research, innovation trial centers, and product applications. The zone serves as a precise platform for international cooperation, commercial transactions, academic discussions, and information exchange.

(The following is a tentative schedule; specific speakers and topics are subject to change on-site.)

Guest Attendance Confirmation Deadline: August 3

09:00-09:05

▸ Conference Address

Hainan Provincial Leaders (Proposed)

09:05-09:10

▸ Conference Address

Leaders of the National Health Commission (proposed)

09:10-09:15

▸ Conference Address

CountryNMPALeader(Draft)

09:15-09:20

▸ Conference Address

WHO Representative (Proposed)

09:20-09:30

▸ Hainan Initiative on Digital Therapeutics

09:30-09:35

▸ 《2023 Global Digital Therapeutics Industry Report》Report Release Ceremony

09:35-09:45

▸ “2023 World Best Innovation and Practice Enterprises in Digital Therapeutics” Award Ceremony

09:45-09:55

▸ Inauguration Ceremony for the Implementation of Innovative Application Scenarios and Solutions in Digital Therapeutics in Hainan

Representative of Hainan-based Digital Therapeutics Implementation Enterprises

09:55-10:00

▸ Opening Ceremony Launch Event

10:00-10:10

▸ Rest

10:10-10:40

▸ “Hainan Riding the Wind: Progress in Building a Global Digital Therapeutics Innovation Island”

Zhou Changqiang | Secretary of the Party Committee and Director, Hainan Provincial Health Commission

10:40-11:10

▸ Development and Prospects of Digital Technology in the Healthcare Sector

Thomas C. Südhof | Winner of the 2013 Nobel Prize in Physiology or Medicine

11:10-11:40

▸ Digital Therapeutics: Pioneering a New Paradigm for the Global Healthcare Industry

DTA/OECD Representative (Proposed)

11:40-12:10

▸ Digital Therapeutics: A Grand Era, Major Opportunities, and Profound Transformation

Jiang Tianjiao | Dean of VCBeat Research Institute

14:00-14:10

▸ Conference Address

Chairman of the Youth Committee, Chinese Health Economics Society

14:10-14:40

▸  Challenges to Establish Sustainable Health Coverage: What technological leaps bring to the establishment of health systems？

President of the World Health Economics Conference

14:40-15:10

▸ Strategic Innovation Models for Health Promotion in China in the New Era

Han Demin | Academician of the Chinese Academy of Engineering (Designate)

15:10-15:40

▸ Upholding the Vision of a Global Community of Health for All

Department of International Cooperation, National Health Commission

15:40-16:10

▸ Exploring the Future Healthcare System

Zhang Zhenzhong | Vice President and Secretary-General of the Chinese Society of Health Economics

16:10-16:40

▸ The Strategic Value of Digital Therapeutics for the Future Healthcare System and the Global Community of Health for All

Zhang Yuhui | Deputy Director of the Hainan Provincial Health Commission (on temporary assignment), Deputy Director of the Health Development Research Center of the National Health Commission

16:40-17:30

▸ Roundtable Discussion (Tentative):

1. Innovation in the Global Health System Reshaped by Digital Technologies;

2. How the healthcare system drives innovation in health services and enhances their quality;

3. Challenges and Key Pathways in Advancing the Coordinated Development and Governance of Medical Insurance, Healthcare Services, and Pharmaceuticals;

4. The Role and Mechanism of Digital Therapeutics in the Construction of Healthy China.

Policy Makers and Representatives of Experts and Scholars

14:00-14:30

▸ Digital Empowerment in Oncology: Clinical Applications and Practical Implementation

Cai Xiujun | President (Designate), Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

14:30-15:00

▸ Digital Health Offers New Approaches to Cancer Survivorship Management

Fan Daiming | Academician of the Chinese Academy of Engineering (nominee)

15:00-15:30

▸ Development and Innovative Advancement of First-in-Class Anti-Tumor Drugs in the Digital Wave

Tan Weihong | Academician of the Chinese Academy of Sciences (proposed)

15:30-16:00

▸ Technological Innovation Empowers the Development of Precision Oncology (Proposed)

Song Erwei | Academician of the Chinese Academy of Sciences, Clinical Oncologist

16:00-16:20

▸ Agenda to be determined

Huang Yunchao｜President, Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University)

16:20-16:40

▸ Post-Consultation Disease Management: Seizing the Moment to Co-create a Digital Health Innovation Ecosystem (Draft)

Guohong Shan | Senior Vice President, Global, Takeda Pharmaceutical; President, Takeda China

16:40-17:00

▸ Agenda to be determined

Li Shaochun | General Manager, Yunnan Baiyao Smart Technology; CDO

17:20-17:40

▸ Topic to be determined

Yao Yixin | Chief Medical Officer, Elsevier Greater China; Ph.D., New York University School of Medicine

17:40-18:00

▸ Agenda to be determined

Sun Fei | Founder of Jinkang Medical Management Consulting

14:00-14:30

▸ Application Practices of Innovative Medical Research in the Digitalization of Chronic Disease Management

Ning Guang | Academician of the Chinese Academy of Engineering (proposed)

14:30-14:50

▸ From Big Data to Full-Cycle Human Health Management (Proposed)

Wu Xifeng | Dean and Professor, School of Public Health, Zhejiang University School of Medicine; Vice President, The Second Affiliated Hospital, Zhejiang University School of Medicine; Executive Dean, Chen Tinghua College of Global Health, Zhejiang University; Dean, National Institute for Big Data in Health and Healthcare, Zhejiang University

14:50-15:10

▸ Reflections and Development of Digital Diabetes Healthcare (Proposed)

Weng Jianping | Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College

15:10-15:30

▸ Digitally building an integrated chronic disease management system to promote innovation and transformation in healthcare service models

Wang Tao | Professor (Level 2) and Doctoral Supervisor, Department of Nephrology, Peking University Third Hospital; Jointly Appointed Professor, Institute for Global Health Development, Peking University

15:30-15:50

▸ Focusing on Therapeutic Areas + Digitalization to Establish an End-to-End Disease Management Model (Proposed)

Zhu Lili | Vice President, AstraZeneca China; Head of Digital & Commercial Innovation and Commercial Strategy & Excellence

15:50-16:10

▸ Agenda to be determined

Li Xin | Vice President of JD Group, General Manager of the Technology and Product Department at JD Health

16:10-16:30

▸ Agenda to be determined

Gong Yuansong | Vice President, Huawei Consumer Business Group, Smart Wearables & Sports Health Product Line

16:30-16:50

▸ Agenda to be determined

Gu Kejun | Vice President of Innovative Business, Hengrui Medicine

16:50-17:10

▸ Application of Digital Therapeutics in Chronic Brain Diseases

Kang Cheng | CEO, Hangzhou Xuzhishi Technology Co., Ltd.

17:10-17:30

▸ Topic TBD

Zhizhong Medical Representative

17:30-17:50

▸ Topic to be determined

Luca Healthcare Representative

Forum Moderator:

Fan Fangfang | Investment Partner, Medical Business Division, Guoke Longhui

14:00-14:30

▸ Brain Health and Smart Healthcare in the Digital Age

Tianzi Jiang | Director of the Brain Network Group Research Center, Institute of Automation, Chinese Academy of Sciences; Foreign Member of Academia Europaea; IEEE/IAPR/AIMBE Fellow

14:30-14:50

▸ Digital Solutions from Brain Science to Brain Health

Wang Liping | Director (Designate) and Researcher, Institute of Brain Cognition and Brain Diseases, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

14:50-15:10

▸ Innovative Exploration of Digital Diagnosis and Treatment for the Brain: From Minimally Invasive Brain-Computer Interfaces to Nonlinear Neural Dynamics Modeling and Modulation

Zhang Mingjun | Tenured Professor and Doctoral Supervisor, Tsinghua University

15:10-15:30

▸ Cognitive Neural Mechanisms of Executive Function and Their Clinical Applications

Xue Gui | Professor, State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University

15:30-15:50

▸ Topic to be determined

Yan Weiqi | Zhejiang Academy of Medical Sciences, Dean of the Hangzhou Institute for Life Science and Technology Innovation

15:50-16:10

▸ From Information Transmission to Emotional Cognition: Digital Analysis and Application of the Biological Brain

Ma Huan | Qiushi Distinguished Professor, Zhejiang University; Core Researcher, National Frontier Science Center for Brain and Brain-Machine Integration

16:10-16:30

▸ Construction and Application of an Integrated Innovative Platform for Intelligent Diagnostic Subtyping and Precision Treatment of Autism Spectrum Disorder

Zhang Rong | Co-founder of the Autism Research Center at Peking University Health Science Center, Executive Vice Chairman of the Beijing Neuroscience Society

16:30-16:50

▸ Agenda to be determined

Chen Zhixuan | Fellow of the American Psychological Association, Chair Professor at The Education University of Hong Kong, Vice President of The Education University of Hong Kong

16:50-17:10

▸ Identity Crisis in Brain Regions: The Brain Is Not What You Think

John Krakauer | Chair Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation at Johns Hopkins University School of Medicine; Director of the Brain, Learning, Animation, and Movement (BLAM) Lab; Chief Medical Officer and Chief Visionary Officer at MindMaze; External Professor at the Santa Fe Institute and Visiting Professor at the Champalimaud Centre for the Unknown

17:10-17:30

▸ Agenda to be determined

Cao Qun | Founder, Chairman, and General Manager of Xinjing Technology

17:30-17:50

▸ “Hardware-Software Integration”: Collaborative Exploration in Technology and Digital Health

Representative of the Brain Science Industry (Proposed)

09:00-09:20

▸ Advancing Digital Healthcare Through the Convergence of Cutting-Edge Research, Technology, and Real-World Data (Proposed)

Long Hao | Chief Expert in Lung Cancer at Sun Yat-sen University Cancer Center, Fellow of the Royal College of Surgeons of England

09:20-09:40

▸ Digital Pathology and AI-Driven Precision Diagnosis and Treatment

Zhang Jing | Deputy Director of the Yuhang Campus, The First Affiliated Hospital, Zhejiang University School of Medicine

09:40-10:00

▸ Integrated Innovation and Synergistic Development of Digital Health with Public and Commercial Medical Insurance

Xie Chen | Deputy Director, Strategic Development Department, Institute for Global Health and Development, Peking University; Project Director, Cohort Survey on Health Technology Assessment of Medical Robots

10:00-10:20

▸ Agenda to be determined

Representatives of Relevant Industrial Parks in Hainan

10:20-10:40

▸ Agenda to be determined

Representative of Fuxing City Internet Information Industrial Park

10:40-11:00

▸ Agenda to be determined

Gao Yunlong | CEO of Zhilan Health

11:00-11:20

▸ Topic to be determined

MicroCloud AI

11:20-12:30

▸ Roundtable Discussion: “Lessons from International Industrial Innovation Practices in the Context of Globalization” (Tentative)

Representatives of Experts and Scholars

12:30-13:00

▸  《2023 Global Digital Therapeutics Industry Report》Report Interpretation

VCBeat

—— Lunch Break ——

14:00-14:10

▸ Recommendations on UK Healthcare Industry Policies and Business Environment (Proposed)

Mike McCourt | UK Department for Business and TradeCounselor for Life Sciences and Healthcare

14:10-14:20

▸ Recommended Policies and Business Environment for Australia’s Healthcare Industry (Draft)

Andrea Myles | Deputy Consul-General (Commercial), Australian Consulate-General in Guangzhou; Senior Commercial Investment Commissioner, Austrade |

14:20-14:30

▸ Recommendations on Belgium’s Health Industry Policies and Business Environment

Eva Verstraelen | Commercial Consul, Flanders Investment & Trade, Consulate General of the Kingdom of Belgium in Guangzhou

14:30-15:10

▸ Roundtable Discussion: “Commercialization and Implementation of Digital Therapeutics from a Global Perspective” (tentative)

Representative of an International Digital Therapeutics Company

15:10-15:30

▸ Agenda to be determined

Mr. Christopher Gill | Deputy Director, Product Development Strategy, ResMed Headquarters (Australia)

15:30-15:50

▸ Agenda to be determined

Gao Jing | Senior Medical Manager, Uscom; Head of Clinical Medical Department, Uscom China

15:50-16:10

▸ Topic TBD

Aidyn Kussainov｜NX10 CEO

16:10-16:30

▸ Agenda to be determined

Congenica Representative

16:30-16:50

▸ Topic to be determined

Representative of Innovative Enterprises

Conference Time:August 24–26, 2023

Conference Venue:China · Hainan Province · Haikou City · Hilton Haikou Meilan

Organizer:Beijing Danhuang Technology Co., Ltd. (VB100, VCBeat, Eggshell Research Institute), China Primary Health Care Foundation

Organizer:Hainan Danhuang Technology Co., Ltd.

Co-organizers:Youth Health Economics Committee of the Chinese Society of Health Economics

Supporting Organizations:Digital Therapeutics Committee of the China Medical Devices Industry Association, UK Department for Business and Trade, Austrade

Strategic Cooperation:AstraZeneca Investment (China) Co., Ltd., Hainan Eco-Software Park

Partners:Fuxing City Internet Information Industrial Park,Bingpian Technology,Hejia Brain Health,NetRain,Nansu Technology, Shangyi Information Technology,Medical Device Incubator,Zheng'an Health, Zhilan Health(More partner updates coming soon...)

Media Partners:The Medical Community, MedPartner, Bio Valley, Wanyi Medicine, Pharma Ark, Pharma Linker, FT Biology, Bioon, Quick Ask Doctor, E-Pharma Manager, Baijing Chuhai, TIMEDOO, Qingsong Club (more media partnerships to be updated...)

Conference Scale:1,500 people

Share this article to your WeChat Moments,Cannot set group visibility,Caption: With favorable winds and timely currents, we are poised to break new ground. Join us at the 2023 World Digital Therapeutics Conference! Collect 38 likes., you can get it for 399 yuan (including simple lunches for the two-day conference)2023 World Digital Therapeutics ConferenceOne ticket!

Choose one of the two activities to claim; scan the QR code after completing the like collection.Add the WeChat of the Welfare Assistant,RemarksClaim Your Conference Ticket!

(Please note: Your company and name)